XTL Biopharmaceuticals Ltd.

Report Publication Announcement • Nov 3, 2005

C004	��� �� �� ������������� ��"�		2
Public	X T L BIOPHARMACEUTICALS LTD
	4312	Corporation no: 520039470
	Stock Exchange/Market: ��� �� ��
	1996
	352	Hasapir 3 , Nes Ziona 76100 , ,
	Tel: 08-9304444 , Fax: 08-9304445
	E.mail address: rcohen@xtlbio.com	Date of transmission: 03/11/2005
		Time of broadcast: 09:58 09:56:24
		Reference: 2005-02-080965

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate report on other matterDon't use this form if there is more adequate one

XTL Biopharmaceuticals Ltd. to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference
Attached file 22-05_RodmanRenshaw_US_3Nov05_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 04/09/2005
- - -
Name of the Signatory : Burgin Jonathan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Hasapir Telephone: 08-9304440 , Facsimile: 08-9300659 , E-mail: jburgin@xtlbio.com